Skip to content

Guided Imagery and Transcranial Direct Current Stimulation (tDCS) in Women With Chronic Pelvic Pain

TerminatedNot applicableNCT02781103
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

This is a single blind, randomized controlled pilot trial of transcranial direct stimulation (tDCS) intervention or tDCS sham administered with a standardized guided imagery intervention. Up to 25 adult women with chronic pelvic pain will be enrolled and randomized (like a flip of the coin) to achieve a total sample size of 20 women. 10 women in one arm of the study will receive guided imagery with tDCS stimulation. 10 women in the other arm of the study will receive guided imagery with sham tDCS. Subjects will remain blinded until the end of the study.

Study details

Official title
A Randomized Control, Single Blind, Pilot Study of Electroencephalogram (EEG) and Symptoms After Guided Imagery and Transcranial Direct Current Stimulation (tDCS) in Women With Chronic Pelvic Pain
Conditions
Interventions
  • Other: Guided imagery plus active tDCS
  • Other: Guided imagery plus Sham tDCS
Sponsor
Kenneth M Peters, MD
Organization
Corewell Health East
Start date
2017-01-20
Primary completion
2017-02-13
Sex
Female
Age range
from 18 Years to 64 Years
Results posted
No results posted in this snapshot
Countries
United States
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Female * Age 18 to 64 years * Women must either be unable to become pregnant (are surgically sterile or postmenopausal) or must use an approved method of birth control throughout the study period. * Self- reported CPP defined as pelvic pain that is non-cyclical and of at least 6 months duration and refractory to other treatments * Subject agrees to not start any new treatment (medication or otherwise) throughout the study treatment and follow up periods. * Subject agrees to maintain stable doses of all current medications throughout the study treatment and follow-up period. Exclusion Criteria: * Pacemaker * History of seizures during the last 2 years or diagnosis of epilepsy * Currently using tobacco * Parkinson's Disease * Any condition, including neurological or psychiatric illness, which per investigators' judgement may increase subject risk * History of Hunner's lesion in the medical record * Lactation, pregnancy, or refusal to use medically approved/reliable birth control in women of child-bearing potential * Sacral, pudendal Interstim® or spinal cord stimulator that is "on". * Contraindications to tDCS stimulation (e.g. metal in the head, implanted brain medical devices, scalp wounds or infections, etc.) * History of head injury resulting in more than a momentary loss of consciousness during the last 2 years Note: For the sake of preserving scientific integrity, one or more of the eligibility criteria have been left off the list posted while the trial is ongoing. A full list of eligibility criteria will be posted upon completion of the trial.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02781103